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CASE REPORT
A 73-year-old woman experienced sudden left hemi-
plegia in November 2006. She was admitted to a near-
by hospital for treatment and tests for cerebral embo-
lism. Her medical and family history were not 
particular noteworthy. During hospitalization, an elec-
trocardiogram （ECG） showed tachycardiac atrial fibril-
lation. Echocardiography was conducted due to suspi-
cion of cardiogenic cerebral embolism and a giant 
tumor mass was found in the right atrium. After reha-
bilitation, the patient was referred to Dokkyo Medical 
University Hospital for a complete examination in May 
2007.
At the time of hospitalization, the patient was of 
height 149 cm, body weight 49 kg, blood pressure 
102/64 mmHg, body temperature 36.6℃, pulse 72/min, 
regular pulse. Left hemiplegia was observed, but the 
patient was clearly conscious and no anemia or jaun-
BACKGROUND
Primary cardiac malignant lymphoma is a rare dis-
ease, making up less than 1％ of all lymphomas 1） and 
accounting for 1.3-2％ of primary cardiac tumors 2）. 
We report a case of rapidly growing cardiac malignant 
lymphoma in the right atrium complicated with paroxi-
mal atrial fibrillation and cardiogenic cerebral embo-
lism. The tumor was diagnosed as Burkitt-like diffuse 
large B-cell lymphoma （Burkitt-like DLBCL） from im-
munohistological findings in biopsy tissue and was im-
proved significantly by chemotherapy.
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SUMMARY
A previously healthy 73-year-old woman was admitted to hospital for sudden left hemiplegia, and an elec-
trocardiogram showed transient atrial fibrillation. Transthoracic and transesophageal echocardiography, 
chest computed tomography, magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission to-
mography led to diagnosis of a giant right atrial tumor infiltrating the right ventricle. A cardiac tumor was 
found upon occurrence of cardiogenic cerebral embolism induced by paroxysmal atrial fibrillation. Trans-
venous atrial tumor biopsy gave a definite diagnosis of Burkitt-like diffuse large B-cell lymphoma, which 
was improved by THP-COP therapy consisting of cyclophosphamide, pirarubicin, vincristine and prednisolo-
ne. Our case shows that early diagnosis and prompt treatment of progressive cardiac lymphoma are impor-
tant.
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dice was found. Heart or pulmonary sounds showed no 
abnormalities, and the liver, spleen and superficial 
lymph nodes were impalpable.
After hospitalization, hematological tests showed 
WBC 4,100/ml, hemoglobin 12.4 g/dl, platelet count 9.4
×104/ml, CRP 2 .45 mg/dl, lactate dehydrogenase 
（LDH） 334 IU/l, and soluble interleukin-2 receptor 
7,245 IU/ml, all of which were significantly elevated. 
ECG showed an ectopic atrial rhythm and a pulse rate 
of 74 beats/min. Chest X-ray showed prominence of 
the right second arch, a cardiothoracic ratio of 67％, 
and a normal lung field （Fig. 1, left）.
Transthoracic echocardiography revealed a giant 
solid tumor-like structure in the periphery of the right 
atrium to the ascending aorta （Fig. 2, upper left）. This 
tumor filled the inside of the right atrium, had infiltrat-
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Fig. 1　 Chest X-ray before chemotherapy （left）, showing the prominence of the right 
second arch, and after chemotherapy （right）.
Fig. 2　 Transthoracic echocardiographic images before （upper left and upper right） and 
after （lower right） chemotherapy from apical four-chamber view. Large tumor was 
in the right atrium （upper right, arrows） and disappeared after chemotherapy. RA, 
right atrium；RV, right ventricle；LA, left atrium；LV, left ventricle.
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ed into the interatrial septum and appeared uneven 
and non-homogenous （Fig. 2, upper right, arrows）. 
Mild aortic valve regurgitation was also recognized. 
Transesophageal echocardiography （TEE） showed a 
giant tumor of 6×4 cm ranging from the periphery of 
the right atrium to the superior vena cava, and con-
trast chest computed tomography （CT） and axial 
magnetic resonance imaging （MRI） suggested a lobu-
lated giant tumor in the right atrium, which had partly 
infiltrated into the right ventricle （Fig. 3, left）. The tu-
mor occupied the ventral anterior of the right-sided 
heart and the blood stream ran into the lungs via the 
dorsal side. The left-sided heart was pressed by the 
tumor to the left posterior, and the ventral anterior 
side of the superior vena cava was narrowed and fila-
ment-like；however, there was no stenosis in the infe-
rior vena cava. In 18F-labeled fluorodeoxyglucose 
（FDG） positron emission tomography （PET） images, 
FDG was significantly concentrated from the right 
atrium to the right ventricle, but there was no evi-
dence for a primary or metastatic focus beyond the 
heart （Fig. 4）. A right atrium image in a cardiac cath-
eter examination confirmed that the tumor occupied a 
large part of the right atrium, and a portion of the tu-
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Fig. 3　 Computed tomography （CT） before （left） and after （right） chemotherapy. The 
giant tumor in the right atrium infiltrated into the right ventricle （left）. RA, right 
atrium；RV, right ventricle；LA, left atrium；LV, left ventricle；A, aorta.
Fig. 4　 FDG-PET in coronal （right） and transaxial （left） views before treatment. 
There was intense FDG uptake （red color area） in the giant mass in the 
right atrium. The blue arrow indicates the giant cardiac lymphoma in the 
right atrium.
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mor mass in the right atrium was collected using a 
catheter for myocardial biopsy. No abnormalities in the 
coronary artery were apparent in coronary arteriogra-
phy.
Images of biopsy tissues suggested infiltration of tu-
mor cells into the atrial muscle fiber （Fig. 5A）. The 
nucleus of each cell differed in size, the nucleolus was 
clear, and a starry sky appearance characteristic of a 
Burkitt-type tumor was observed in tumor cells （Fig. 
5B）. Based on CD20-positive （Fig. 5C）, Bcl 2 100％ 
positive （Fig. 5D） and MIB-1 stain index over 90％ 
findings, the tumor was diagnosed as Burkitt-like dif-
fuse large B-cell lymphoma （Burkitt-like DLBCL）. 
Considering the age of the patient and the tumor 
stage, 5 courses of THP-COP therapy consisting of cy-
clophosphamide, pirarubicin, vincristine and predniso-
lone were conducted. The tumor responded to chemo-
therapy very well：chest X-ray showed a decrease of 
54％ in the cardiothoracic ratio （Fig. 1, right）, and 
echocardiography and MRI showed a significantly de-
creased right atrial tumor （Fig. 2, lower left；Fig. 3, 
right）. After improvement of lymphoma was con-
firmed, the patient was discharged. Currently, she vis-
its the hospital regularly and has not experienced a re-
currence, although an electrocardiogram indicates an 
ectopic atrial rhythm.
DISCUSSION
Among primary cardiac tumors, 75％ are benign 
and half are myxoma. Of cases of cardiac malignant 
lymphoma, the peak incidence is at an age of 62-67 
years old, the disease occurs more in males than in fe-
males, and 69-72％ occur in the right-sided heart 2）. 
The common sites of extra-nodal malignant lymphoma 
are the mediastinum 3）, stomach, skin and central ner-
vous system, with few cases reported in the heart. 
Cardiac malignant lymphomas are mostly metastatic 4）. 
Diffuse large B-cell lymphoma （DLBCL） accounts for 
30-40％ of adult non-Hodgkin’s lymphoma cases and 
extra-nodal lymphoma develops as a tumor mass and 
grows more rapidly than nodal lymphoma. The tumor 
can grow to a gigantic size.
Similarly to other tumors, cardiac malignant lympho-
ma develops asymptomatically and has non-character-
istic symptoms such as shortness of breath. Some cas-
es show symptoms of exertional dyspnea, palpitation, 
syncope, acute heart failure due to atrioventricular 
block 5〜7）, and supraventricular arrhythmia such as 
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Fig. 5　 Histological findings in biopsy tissue. In a hematoxylin-eosin-stained 
specimen, lymphoma cells had diffusely infiltrated the right atrial 
muscle fiber （A） and a starry sky appearance of undifferentiated 
large lymphoid cells was apparent （B）. Immunohistological staining 
was clearly positive for CD20 （C） asnd Bcl 2 （D）.
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atrial fibrillation （as in the current case） and right 
ventricular failure 8）. Sonoda et al. also reported com-
plete atrioventricular block and superior vena cava 
syndrome in a patient with giant cardiogenic malig-
nant lymphoma 9）. Cancer is a major risk factors for 
thrombotic pulmonary embolism 10） and a fatal case of 
developing pulmonary embolism has been reported 11）, 
but there has been no previous report of cardiac ma-
lignant lymphoma complicated with cerebral embolism 
induced by paroximal atrial fibrillation.
In our case, chest X-ray demonstrated moderate 
cardiomegaly on the right cardiac side 12）. Transthorac-
ic and transesophageal echocardiography （TEE）6, 13）, 
chest CT and MRI are useful for diagnosis 5, 7, 12, 14）, and 
FDG-PET is effective for examination of metastasis 
and pathologic conditions 3, 15）. Tumor biopsy is essen-
tial for definite diagnosis and selection of therapy to 
confirm whether the lymphoma is highly responsive to 
chemotherapy and is curable 6, 8, 12）. Patients have been 
treated with chemotherapy such as CHOP therapy 
consisting of cyclophosphamide, adriamycin, vincristine 
and prednisolone 8, 13）. The patient in our case was 
treated with THP-COP therapy due to her age and 
this treatment was successful. Other therapeutic meth-
ods have been reported, including use of Rituximab-
CHOP therapy with addition of an anti-CD20 monoclo-
nal antibody 14） and combination therapy of Rituximab-
CHOP and high-dose chemotherapy with autologous 
peripheral blood stem cell transplantation 15）. 
Right atrial lymphoma is often accompanied by ar-
rhythmia, as mentioned above, and may damage the 
stimulus-conducting system by infiltration of atrial tu-
mors into the atrial muscle. Therefore, the system can-
not be restored completely in many cases, even after 
remission of lymphoma. In our case, ectopic atrial 
rhythm is present currently and we plan a complete 
follow-up observation of the patient. Primary cardiac 
malignant lymphoma has also recently been associated 
with post-transplantation and human immunodeficient 
virus （HIV） infection 16）, suggesting that this disease 
may occur in several different contexts. Therefore, we 
report our case as an example of the importance of 
early diagnosis and prompt treatment of patients with 
progressive cardiac lymphoma.
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